Rifampicin-resistant tuberculosis in Fujian Province, Southeast China: a retrospective analysis of drug resistance screening and treatment outcomes, 2019–2024

QR Code

Rifampicin-resistant tuberculosis in Fujian Province, Southeast China: a retrospective analysis of drug resistance screening and treatment outcomes, 2019–2024

BackgroundsRifampicin-resistant tuberculosis (RR-TB) remains a major challenge to global TB control efforts. In Fujian Province, Southeast China, where RR-TB prevalence has been notably high, understanding epidemiological trends and treatment outcomes is crucial for optimizing interventions. This st...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yinfa Zhou, Zhisong Dai, Shufang Lin, Daiquan Chen, Jian Lin, Kun Chen, Yongming Lin, Yanqin Deng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Public Health
Subjects:	tuberculosis rifampicin-resistant treatment outcome epidemiology regression analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2025.1611459/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01)

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01)

Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India
by: Hindol Mondal, et al.
Published: (2025-07-01)

Health-related quality of life of patients with rifampicin-resistant/multidrug-resistant tuberculosis in Vietnam: a prospective follow-up study
by: Nguyen Vu Anh Thu, et al.
Published: (2025-07-01)

Diagnostic Modalities for Detecting Extrapulmonary Tuberculosis and Resistance Patterns of Rifampicin and Isoniazid at a Referral Hospital: A Retro Prospective Study
by: Ankur Kumar, et al.
Published: (2025-04-01)

Beyond treatment and cure: Burden of adverse drug reactions in a case of multidrug-resistant tuberculosis
by: Sagarika N. Suresh, et al.
Published: (2025-01-01)

Impact of COVID-19 pandemic on tuberculosis
by: Sae Pol, et al.
Published: (2025-01-01)

Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01)

A single patient with both pulmonary tuberculosis and borderline leprosy, accompanied by a Type-II leprosy reaction
by: Madhav Mahawar, et al.
Published: (2025-01-01)

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis
by: Tomasz Bogiel, et al.
Published: (2025-06-01)

Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions in Patients with Pulmonary Tuberculosis Who Received Isoniazid and Rifampicin
by: A. A. Kachanova, et al.
Published: (2021-03-01)

Molecular Analysis of Rifampicin Resistance Conferring Mutations in Mycobacterium tuberculosis
by: Tawgozy et al.
Published: (2020-05-01)

Pathological Changes of Rifampicin Toxicity on Some Organs in Rats
by: Dalia Amer Khudhair
Published: (2025-04-01)

Early Administration of Rifampicin Does Not Induce Increased Resistance in Septic Two-Stage Revision Knee and Hip Arthroplasty
by: Leonard Grünwald, et al.
Published: (2025-06-01)

Dinucleotide codon substitutions as a signature of diversifying selection in Mycobacterium tuberculosis
by: Danila Zimenkov, et al.
Published: (2025-07-01)

GeneXpert MTB/RIF Assay of Pulmonary Tuberculosis and HIV Co-Infection at a Central TB Referral Centre in Anambra State, Nigeria
by: Rita Nweke, et al.
Published: (2025-08-01)

Clozapine and tuberculosis treatment: a case report and literature review
by: Neel Swamy, et al.
Published: (2025-07-01)

Comparison of Truenat Mycobacterium tuberculosis with line probe assay for the diagnosis of rifampicin resistance and mutation pattern of Mycobacterium tuberculosis
by: Pratik Kumar, et al.
Published: (2025-07-01)

Effect of sepiolite on the physical properties and swelling behavior of rifampicin-loaded nanocomposite hydrogels
Published: (2009-08-01)

Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus
by: Jalal Ghaderkhani, et al.
Published: (2019-12-01)

Carriage of Rifampicin- and Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in Apparently Healthy Camels: A View Through a Zoonosis Lens
by: Dalia Hamza, et al.
Published: (2025-05-01)

In Vitro and Ex Vivo Evaluation of Rifampicin Cytotoxicity in Human Skin Models
by: Marcel Nani Leite, et al.
Published: (2025-07-01)

Formulation of Topical Drug Delivery Systems Containing a Fixed-Dose Isoniazid–Rifampicin Combination Using the Self-Emulsification Mechanism
by: Melissa van Deventer, et al.
Published: (2025-05-01)

Mutations associated with resistance to rifampicin and isoniazid identified in strains of the Mycobacterium tuberculosis complex by GenoType MTBDRplus in Panama, 2015–2021
by: Juan Domínguez González, et al.
Published: (2025-07-01)

Apoptosis-Inducing Action of Antituberculosis Drugs of the Main Group in Vitro
by: O. A. Vasilyeva, et al.
Published: (2020-05-01)

Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres
by: ZeWen Qiao, et al.
Published: (2019-12-01)

Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success
by: Eleonore Fröhlich, et al.
Published: (2025-07-01)

A comparative study of accuracy between gene Xpert (cartridge-based nucleic acid amplification test) and line probe assay in retreatment cases of sputum-positive pulmonary tuberculosis
by: Upendra Kumar, et al.
Published: (2025-07-01)

Mitigating Tuberculosis Drug-induced Liver Injury: The Role of Moringa oleifera and Other Herbal Extracts
by: Herin Mawarti, et al.
Published: (2025-04-01)

Effect of rifampicin on Toll-like receptor system gene expression in brain structures of rats with prenatal alcohol exposure
by: M. I. Airapetov, et al.
Published: (2025-01-01)

Early adopters of 6-month levofloxacin as rifampicin-resistant tuberculosis preventive treatment regimen in the WHO European Region, 2023
by: Andrei Dadu
Published: (2025-07-01)

Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study
by: Wang J, et al.
Published: (2025-07-01)

Potential Role of Whole Genome Sequencing to Predict the Virulence, Anti-TB Resistance, and Variants of Mycobacterium tuberculosis Strains from Rifampicin-sensitive Pulmonary Tuberculosis Patients in Surabaya, East Java, Indonesia
by: Ni Made Mertaniasih, et al.
Published: (2025-04-01)

Prediction of risk factors associated with the development of multidrug-resistant tuberculosis in patients with tuberculosis
by: Haiyan Chen, et al.
Published: (2025-07-01)

Drug resistance patterns, trends, and risk factors for multidrug resistance of tuberculosis in Wenzhou, China: a ten-year retrospective analysis (2014–2023)
by: Lianpeng Wu, et al.
Published: (2025-07-01)

Cycloserine resistance among drug-resistant tuberculosis cases in Taiwan
by: Sheng-Han Wu, et al.
Published: (2025-07-01)

Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis.
by: Matthew Arentz, et al.
Published: (2013-01-01)

Resistance pattern and profile of patients with drug-resistant tuberculosis at a tertiary care center
by: Pratik Kumar, et al.
Published: (2025-07-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)